CMR Surgical submits 510(k) for gynecology
Versius Plus is intended for benign gynecologic procedures including total hysterectomy, oophorectomy, and salpingectomy.
See the latest news and media coverage for CMR Surgical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Modular surgical robotics and perioperative digital systems
cmrsurgical.comLast updated
In short: CMR Surgical secured FDA clearance for its Versius Plus system and reached a global milestone of 45,000 procedures across more than 30 countries.
Versius Plus is intended for benign gynecologic procedures including total hysterectomy, oophorectomy, and salpingectomy.
The announcement at SAGES2026 marks a milestone, reaching 45,000 patients across 30+ countries and now the U.S.
CMR contributes 500 hours of surgical data to Open-H dataset for training intelligent robotic systems. It supports Versius development using NVIDIA technologies.
Chris O’Hara speaks on robotics choice. Versius® Plus gains U.S. 510(k) clearance for adult cholecystectomy.
CMR Surgical, a global medical technology business, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for...
Press release - DataM intelligence 4 Market Research LLP - Surgical Robotics Market to Reach US$15.25 Billion by 2033 at 11.3% CAGR; North America Leads...
CMR Surgical reveals that more than 45,000 patients worldwide have now been treated using its Versius® Surgical Robotic System, marking a major milestone for the...
The company is formally introducing its Versius robot at a surgeons' meeting this week in what CEO Massimiliano Colella described as a "watershed moment" for...
Track CMR Surgical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CMR Surgical and other trending companies.